More
    Guided Solutions - Connecting Talent With Innovation/div>

    FDA clears Ekso Bionics’ robotic exoskeleton for use with MS patients

    Ekso Bionics (Nasdaq:EKSO) announced that it received FDA 510(k) clearance for its EksoNR robotic exoskeleton. Richmond, California–based Ekso Bionics designed the EksoNR technology for use with...

    Rune Labs scores FDA 510(k) to monitor Parkinson’s symptoms

    The StrivePD app uses Apple's Movement Disorder API to track tremors and uncontrolled body movement. Brain data startup Rune Labs announced Tuesday it received FDA 510(k) clearance to use...

    EarliTec Diagnostics Receives FDA 510(k) Clearance for the EarliPoint Evaluation for Autism Spectrum Disorder

    EarliTec Diagnostics, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism spectrum disorder (ASD) and early childhood...

    FDA clears lumbar interbody fusion device from Zavation Medical

    Zavation Medical announced that it received FDA 510(k) clearance for its eZspand lateral expandable lumbar interbody fusion device. Flowood, Mississippi-based Zavation designed the eZspand lateral, part...

    US FDA approves Medicalgorithmics’ Qpatch ECG monitoring device

    The device includes an eInk screen that allows physicians and patients to interact with the wearable. The US Food and Drug Administration (FDA) has approved Medicalgorithmics’ ECG...

    Okami Medical secures FDA 510k clearance for vascular occluders

    LOBO-7 and LOBO-9 are intended for use in 5mm to 7mm and 7mm to 9mm diameter vessels, respectively. Okami Medical has received 510k clearance from the US...

    Aurora Spine Corporation Receives FDA 510(k) Clearance for DEXA SOLO-LTM Anterior Lumbar Interbody Fusion Device as part of its DEXA Technology Platform

    Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes,...

    FDA clears Abbott’s next-gen FreeStyle Libre 3 14-day CGM

    Abbott  announced that it received FDA clearance for its next-generation FreeStyle Libre 3 continuous glucose monitor. FDA clearance for the latest iteration of the company’s...

    FDA approves Medtronic’s In.Pact 018 drug-coated balloon catheter

    Medtronic  announced that it received FDA approval for its In.Pact 018 paclitaxel-coated balloon catheter. Fridley, Minnesota-based Medtronic’s In.Pact 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon...

    Latest articles